ECOR - ElectroCore Inc Stock Price, Fair Value and News

$4.96+0.21 (+4.42%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ECOR Price Action

Last 7 days

1.2%

Last 30 days

-2.4%

Last 90 days

0.6%

Trailing 12 Months

-55.2%

ECOR RSI Chart

ECOR Valuation

Market Cap

39.7M

Price/Earnings (Trailing)

-2.8

Price/Sales (Trailing)

1.33

EV/EBITDA

-2.24

Price/Free Cashflow

-4.67

ECOR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ECOR Fundamentals

ECOR Revenue

Revenue (TTM)

29.8M

Rev. Growth (Yr)

32.58%

Rev. Growth (Qtr)

17.72%

ECOR Earnings

Earnings (TTM)

-14.2M

Earnings Growth (Yr)

-36.36%

Earnings Growth (Qtr)

7.25%

ECOR Profitability

EBT Margin

-47.52%

Return on Equity

1.3K%

Return on Assets

-66.13%

Free Cashflow Yield

-21.39%

ECOR Investor Care

Shares Dilution (1Y)

21.99%

Diluted EPS (TTM)

-1.69

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	26.5M	27.7M	29.8M	0
2024	18.7M	21.3M	23.3M	25.2M
2023	9.5M	10.9M	13.4M	16.0M
2022	6.1M	7.0M	7.5M	8.6M
2021	4.0M	4.5M	4.9M	5.5M
2020	2.7M	2.8M	3.2M	3.5M
2019	1.3M	1.6M	2.1M	2.4M
2018	322.5K	546.0K	769.5K	993.0K
2017	0	0	0	99.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About ElectroCore Inc

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

CEO	Mr. Daniel S. Goldberger
WEBSITE	electrocore.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	62

ElectroCore Inc Frequently Asked Questions

What is the ticker symbol for ElectroCore Inc? What does ECOR stand for in stocks?

ECOR is the stock ticker symbol of ElectroCore Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ElectroCore Inc (ECOR)?

As of Wed Dec 03 2025, market cap of ElectroCore Inc is 39.66 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ECOR stock?

You can check ECOR's fair value in chart for subscribers.

Is ElectroCore Inc a good stock to buy?

The fair value guage provides a quick view whether ECOR is over valued or under valued. Whether ElectroCore Inc is cheap or expensive depends on the assumptions which impact ElectroCore Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ECOR.

What is ElectroCore Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, ECOR's PE ratio (Price to Earnings) is -2.8 and Price to Sales (PS) ratio is 1.33. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ECOR PE ratio will change depending on the future growth rate expectations of investors.